17β-estradiol prevents programmed cell death in cardiac myocytes

Biochemical and Biophysical Research Communications

Volumn 268, Issue 1, 2000, Pages 192-200

  Pelzer, Theo ^a   Schumann, Michael ^a   Neumann, Manfred ^a   DeJager, Tertia ^a   Stimpel, Michael ^a   Serfling, E ^a   Neyses, Ludwig ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Cardiac muscle; Caspase 3; Estrogen; NF B

Indexed keywords

CASPASE 3; ESTRADIOL; HOE 33342; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAUROSPORINE; TRANSCRIPTION FACTOR; CASP3 PROTEIN, RAT; CASPASE; DNA FRAGMENT;

APOPTOSIS; ARTICLE; CELL STRUCTURE; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; HORMONAL REGULATION; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; VITAL STAIN; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; HEART; HEART MUSCLE; METABOLISM; NUCLEOSOME; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PHASE CONTRAST MICROSCOPY;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CASPASE 3; CASPASES; CELLS, CULTURED; DNA FRAGMENTATION; ESTRADIOL; HEART; IN SITU NICK-END LABELING; MICROSCOPY, PHASE-CONTRAST; MYOCARDIUM; NF-KAPPA B; NUCLEOSOMES; OLIGONUCLEOTIDE PROBES; RATS; STAUROSPORINE;

EID: 0034606788     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2073     Document Type: Article

References (34)

1. Grodstein F., Stampfer M. J. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog. Cardiovasc. Dis. 38:1995;199-210.
2. Gordon T., Kannel W. B., Hjortland M. C., McNamara P. M. Menopause and coronary heart disease: The Framingham study. Ann. Intern. Med. 89:1978;157-161.
3. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. J. Med. 325:1991;756-762.
4. Haunstetter A., Izumo S. Apoptosis, basic mechanisms and implications for cardiovascular disease. Circ. Res. 82:1998;1111-1129.
5. Wang T. T., Phang J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55:1995;2487-2489.
6. Grohe C., Kahlert S., Löbbert K., Stimpel M., Karas H., Vetter H., Neyses L. Cardiac myocytes contain functional estrogen receptors. FEBS Lett. 416:1997;107-112.
7. Simpson P., Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol. Circ. Res. 50:1982;101-116.
8. Tieger E., Dam T., Richjard L., Wisnewsky C., Tea B., Gaboury L., Tremblay J., Schwartz K., Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97:1996;2891-2897.
9. Lizard G., Deckert V., Dubrez L., Moisant M., Gambert P., Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am. J. Pathol. 148:1996;1625-1638.
10. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
11. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
12. Lassar A. B., Buskin J. N., Lockshon D., David R. L., Apone S., Hauschka S. D., Weintraub H. MyoD is a sequence specific DNA binding protein requiring a myc homology to bind to the muscle creatine kinase enhancer. Cell. 58:1989;823-831.
13. Briegel K., Hentsch B., Pfeuffer I., Serfling E. One base pair change abolishes the T cell-restricted activity of a κB-like proto-enhancer element from the interleukin 2 promoter. Nucleic Acids Res. 19:1991;5929-5936.
14. Brown D. G., Sun X. M., Cohen G. M. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268:1993;3037-3039.
15. Elsasser A., Schlepper M., Klovekorn W. B., Cai W. J., Zimmermann R., Muller K. D., Strasser R., Kostin S., Gagel C., Munkel B., Schaper W., Schaper J. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation. 96:1997;2920-2931.
16. Majno G., Joris I. Apoptosis, oncosis and necrosis: On overview of cell death. Am. J. Pathol. 146:1995;3-15.
17. Kirshenbaum L. A., de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
18. Baeuerle P., Baltimore D. NF-κB: Ten years after. Cell. 87:1996;13-20.
19. Grimm S., Bauer M., Baeuerle P. A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134:1996;13-23.
20. Walter P., Green S., Krust A., Bornert J. M., Jeltsch J. M., Staub A., Jensen E., Scrace G., Waterfield M., Chambon P. Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci. USA. 82:1985;7889-7893.
21. Kuiper G. G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J. A. Cloning of a novel estrogen receptor expressed in the rat prostate and ovary. Proc. Natl. Acad. Sci. USA. 93:1996;5925-5930.
22. Wilson J. W., Wakeling A. E., Morris I. D., Hickman J. A., Dive C. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int. J. Cancer. 61:1995;502-508.
23. Kolodgie F. D., Farb A., Litovsky S. H., Narula J., Jeffers L. A., Lee S. J., Virmani R. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovarectomized rat. J. Mol. Cell Cardiol. 29:1997;2403-2414.
24. Yue T. L., Wang C., Romanic A. M., Kikly K., Keller P., DeWolf W. E., Hart T. K., Thomas H. C., Storer B., Gu J. L., Wang X., Feuerstein G. Z. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. Mol. Cell Cardiol. 30:1998;495-507.
25. Krown K. A., Page M. T., Nguyen C., Zechner D., Gutierrez V., Comstock K. L., Glembotski C. C., Quintana P. J., Sabbadini R. A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98:1996;2854-2865.
26. Black S. C., Huang J. Q., Rezaiefar P., Radinovic S., Eberhart A., Nicholson D. W., Rodger I. W. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo. J. Mol. Cell Cardiol. 4:1998;733-742.
27. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
28. May M., Ghosh S. Signal transduction through NF-κB. Immunol. Today. 19:1998;80-88.
29. Sawa Y., Morishita R., Suzuki K., Kagisaki K., Kaneda Y., Maeda K., Kadoba K., Matsuda H. A novel strategy for myocardial protection using in vivo transfection of cis element "decoy" against NFkappaB binding site: Evidence for a role of NFkappaB in ischemia-reperfusion injury. Circulation. 96:1997;II-II2804.
30. Morishita R., Sugimoto T., Aoki M., Kida I., Tomita N., Moriguchi A., Maeda K., Sawa Y., Kaneda Y., Higaki J., Ogihara T. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nature Med. 8:1997;894-899.
31. Wong S. C., Fukuchi M., Melnyk P., Rodger I., Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation. 98:1998;100-103.
32. McKay L. I., Cidlowski J. A. Cross-talk between nuclear factor-κB and the steroid hormone receptors: Mechanism of mutual antagonism. Mol. Endo. 12:1998;45-56.
33. Ray P., Ghosh S., Zhang D. H., Ray A. Repression of interleukin-6 gene expression by 17-β estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor. FEBS Lett. 409:1997;79-85.
34. Barkett M., Xue D., Horvitz H. R., Gilmore T. D. Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272:1997;29419-29422.